News
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
7d
Verywell Health on MSNNot an 'Easy Way Out': How GLP-1 Users Navigate the Stigma of Weight Loss DrugsDespite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results